Immunology Company Kira Biotech launches with A$20M Series A Funding
Related Articles
-
Dreadlocks anyone?
Cristian Silveira donates money raised to Dendritic Cell Research Cristian Silveira had been growing his hair for about 17...
-
The First Ladies
Featured in Burwood Scene, August 7, 2013. The Inner west will be well served by four full-time working women as...
-
ANZAC Research Institute Medical Appeal
Launch Speech by Burwood Scene Editor Belinda Noonan on 29 May 2013. I met Professor Derek Hart at Concord...
-
2015 – What a Year for DCR!
2015 has been a great year for Dendritic Cell Research. DC Down Under 2015 was another great success. With...
-
Government supports blood cancer research
Featured in ANZAC Institute Discovery, May 2012. The NSW Government has awarded $3.47 million over 5 years in a...
-
Bendigo Bank Supports ANZAC Research Institute Research Fight for Leukaemia
The Dendritic Cell Biology and Therapeutics Group (DCBTG) at the ANZAC Research Institute is a specialized facility focused on...
-
New clinical antibody created using the science of gene cloning
Dendritic Cell Research Publish Landmark Paper Dendritic Cell Research (DCR) has a major interest in Dendritic Cell (DC)...
-
John’s Multiple Myeloma Story
Featured in MyeNews, Spring Issue, 2015. John Fullagar gave the consumers perspective at the recent DC Down Under Symposium DC...
![](mailto:?subject=Immunology Company Kira Biotech launches with A$20M Series A Funding&body=
<img class="aligncenter wp-image-3224 size-medium" src="http://dcresearch.org.au/wp-content/uploads/2019/10/Kira-Biotech-logo-300x150.jpg" alt="" width="300" height="150" /><br />
Brisbane, 29 October 2019: Kira Biotech today announced it has secured Series A funding of A$20 million to develop therapeutics targeting difficult-to-treat immune system disorders.
The round was led by OneVentures, with significant investment from IP Group and support from the Advance Queensland Business Development Fund. The funds will help advance Kira Biotech’s lead candidate KB312 through phase 1 human studies. <a style="color: #ffcc00;" href="https://kirabiotech.com/wp-content/uploads/2019/10/20191024-Kira-Biotech-Series-A-funding-press-release.pdf">Read More</a>
http://dcresearch.org.au/immunology-company-kira-biotech-launches-with-a20m-series-a-funding/){kind=link}